Novus Diagnostics Ltd. - 23 Dec 2025 SCHEDULE 13G Report for TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB)

Filing Manager
Novus Diagnostics Ltd.
Reporting Manager
Novus Diagnostics Ltd.
Security
TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares
Symbol
TRIB
Shares outstanding
18,697,629 shares
Disclosed Ownership
1,119,988 shares
Ownership
6%
Form type
SCHEDULE 13G
Filing time
06 Mar 2026, 17:01:08 UTC
Date of event
23 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Novus Diagnostics Ltd. disclosed 6% ownership in TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) on 23 Dec 2025."

Quick Takeaways

  • Novus Diagnostics Ltd. filed SCHEDULE 13G for TRINITY BIOTECH PLC @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB).
  • Disclosed ownership: 6%.
  • Date of event: 23 Dec 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 06 Mar 2026, 17:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Novus Diagnostics Ltd. 6% 1,119,988 1,119,988 0 /s/ Keith O'Neill Keith O'Neill/Chief Executive Officer

Sponsored